We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About OLIPOP Stock

Invest in or calculate the value of your shares in OLIPOP or other pre-IPO companies through EquityZen, part of Morgan Stanley.

Get Started

OLIPOP Stock (OLIP)

OLIPOP is a beverage brand, offering a low-sugar, high-fiber soda made with prebiotics to support digestive health. According to the founder, David Lester, recent scientific studies show its ingredients enhance gut microbiome diversity. The company has secured funding and intends to expand its market share through the introduction of new products and marketing initiatives.

OLIPOP is the clinically backed consumer beverage that meets consumer’s real-world taste preferences in a delicious tonic.

About OLIPOP Stock

Founded

2017

Headquarters

Oakland, CA, US

Total Funding

272M

Industries

Health Care, Food and Beverage

OLIPOP is a functional beverage brand that aims to provide alternatives to traditional soda by supporting digestive and microbiome health. Operating as a Public Benefit Corporation, beverages are made using a trademarked formula, OLISmart, containing botanicals, plant fibers, and prebiotics.

OLIPOP Press Mentions

Stay in the know about the latest news on OLIPOP

OLIPOP Management

Leadership team at OLIPOP

Chief Executive Officer

Christian Patiño Webb

Chief Financial Officer

Tracy Hart

Locked Features

Join now and verify your accreditation status to gain access to:

  • OLIPOP Current Valuation
  • OLIPOP Stock Price
  • OLIPOP Management
  • Available deals in OLIPOP and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • OLIPOP Cap Table and Funding History by Share Class and Liquidity Preferences
    • OLIPOP Revenue and Financials
    • OLIPOP Highlights
    • OLIPOP Business Model
    • OLIPOP Risk Factors
  • OLIPOP Research Report from SACRA Research
Join Now

OLIPOP Key Facts

  • Executive Leadership Enhancement: In August 2026, OLIPOP announced the appointment of Christian Patiño Webb as its new Chief Executive Officer, succeeding co-founder Ben Goodwin, who will transition into a dedicated innovation role. Patiño Webb previously served as the CEO of sports drink brand Electrolit and brings nearly two decades of consumer packaged goods experience. This strategic leadership change is geared toward scaling business operations, investing in talent, and continuing brand expansion within the functional beverage market.
  • Robust Financial Growth and Unicorn Valuation: OLIPOP has demonstrated strong operational execution, achieving profitability while doubling its year-over-year performance to reach $400 million in annual sales in 2024. The company subsequently raised significant capital in a Series C funding round, anchored by institutional investors including J.P. Morgan, which concluded in late 2024 to early 2025. This round elevated OLIPOP to a post-money valuation of $1.85 billion, reinforcing investor confidence and establishing the company as a market leader in the healthy, prebiotic soda category.
  • Significant Retail Expansion and Product Innovation: By 2025, OLIPOP expanded its physical distribution network to nearly 50,000 retail locations across the United States. The company leverages this wide retail footprint alongside an active product pipeline to maintain consumer engagement.
  • Class Action Litigation Over Health Claims: A class-action lawsuit (Somers v. Olipop Inc.) filed in the Eastern District of New York alleges that OLIPOP falsely advertises its prebiotic sodas as providing meaningful digestive health benefits. The complaint contends that a single can contains insufficient fiber (6–9 grams) to achieve prebiotic effects based on cited studies, and that consuming the necessary daily volume would introduce counterproductive levels of sugar. If certified and successful, this ongoing litigation could mandate costly marketing changes, result in financial liabilities, and damage the brand's credibility among its core demographic.
  • Intense Competition and Shifting Consumer Spending: The functional beverage category is experiencing aggressive competition, most notably from rival brand Poppi, which has deployed highly efficient, algorithm-driven digital marketing campaigns to rapidly capture market share. Furthermore, strategic industry analyses warn that OLIPOP faces looming threats from established "Big Soda" conglomerates that possess massive distribution scale.
  • Product Reformulation and Core Proposition Risks: In an effort to expand its distribution footprint, OLIPOP introduced shelf-stable versions of its beverages in 2024 featuring a revised formulation. This new product line replaces its original chicory root and Jerusalem artichoke inulin with acacia and guar fiber, leading to an approximate 30% reduction in total fiber content. Altering the fiber profile to achieve shelf stability risks diluting the brand’s core competitive advantage as a high-fiber digestive health tonic, potentially alienating early adopters and leaving the company vulnerable to competitors highlighting superior nutritional profiles.

Trading OLIPOP Stock

How to invest in OLIPOP stock?

Accredited investors can buy pre-IPO stock in companies like OLIPOP through EquityZen funds. These investments are made available by existing OLIPOP shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.

How to sell OLIPOP stock?

Shareholders can sell their OLIPOP stock through EquityZen's private company marketplace. EquityZen's network includes over 480K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 56K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."